Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Beyond the Genome 2012

Open Access Oral presentation

De novo diagnostics of patients with intellectual disability

Joris A Veltman

  • Correspondence: Joris A Veltman

Author Affiliations

Department of Human Genetics, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands

BMC Proceedings 2012, 6(Suppl 6):O9  doi:10.1186/1753-6561-6-S6-O9


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/6/S6/O9


Published:1 October 2012

© 2012 Veltman; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Oral presentation

Germline coding de novo mutations (SNVs, indels as well as CNVs) are an important cause of moderate to severe forms of intellectual disability (ID) and associated syndromes. Exome sequencing now allows us to reliably identify these mutations using a single genomic test, and we have recently implemented exome sequencing in the diagnostic follow-up of these patients.

In this presentation, I will first discuss the role of de novo mutations in genetic disease and the associated risk factors such as local genomic structure and paternal age. Next, I will describe our recent work using a diagnostic family-based exome sequencing approach to test this de novo mutation hypothesis in 100 patients with unexplained ID, as well as targeted follow-up studies of several candidate ID genes in 750 additional patients. A total of 79 unique coding de novo mutations were identified and validated in 52 patients. Damaging de novo (n = 10) as well as X-linked maternally-inherited (n = 3) mutations were detected in known ID genes, resulting in a minimal diagnostic yield of 13% in this cohort. In addition, potentially causative de novo mutations in novel candidate ID genes were detected in 22 patients. For three of these candidate genes, recurrent de novo mutations were identified in patients with similar phenotypes, confirming that they are true ID genes. To further expand the possibilities of exome sequencing for mutation detection, we have recently implemented automatic CNV detection on exome data, and compared its performance to that of high-resolution genomic microarrays. This analysis shows that exome sequencing can reliably detect the large majority of pathogenic de novo CNVs, responsible for approximately 15% of ID.

In conclusion, de novo mutations therefore represent an important cause of ID, and exome sequencing is an effective diagnostic strategy for their detection.

References

  1. Vissers LELM, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BWM, Hoischen A, de Vries BBA, Brunner HG, Veltman JA: A de novo paradigm for mental retardation.

    Nat Genet 2010, 42:1109-1112. PubMed Abstract | Publisher Full Text OpenURL

  2. Hehir-Kwa JY, Rodríguez-Santiago B, Vissers LE, de Leeuw N, Pfundt R, Pérez-Jurado LA, Veltman JA: De novo copy number variants associated to intellectual disability have a paternal origin and age bias.

    J Med Genet 2011, 48:776-778. PubMed Abstract | Publisher Full Text OpenURL

  3. Veltman JA, Brunner HG: De novo mutations in human genetic disease.

    Nat Rev Genet 2012, 13:565-575. PubMed Abstract | Publisher Full Text OpenURL